| 11.04.2008 Performance: Opalesque Exclusive: 788 China Fund Ltd. down YTD -57% after +114% in 2007, Healthcare hedge fund Accipiter Life Sciences II loses 40% in March, Platinum Grove suffers worst performance since inception in March |
| Opalesque Exclusive: 788 China Fund Ltd. down YTD -57% after +114% in 2007 The 788 China Fund Ltd., which had past annual gains of +33.28% (2006) and +114.82% (2007), began 2008 with a January loss of -39.55% and after a brief February bounce back of +7.63% estimates March returns to be -33.91%. According to corporate documents the fund, managed by Jacques Mechelany, aims to achieve medium to |
| Article source: http://www.reuters.com/article/fundsFundsNews/idUSN1033644420080410 - Opalesque is not responsible for the content of external internet sites |